Pfizer Inc ETR: PFE Dividend History, Dates & Yield
Pfizer Inc. on Tuesday unveiled a new online platform designed to help simplify and coordinate healthcare for consumers, adding momentum to an emerging trend in big pharma that has drawn criticism fro... Pfizer's stock is undervalued with a 48% upside potential, supported by robust product pipelines, strategic initiatives, and a high 5.94% forward dividend yield. SELF does not provide medical advice, diagnosis, or treatment. Any information published on this website or by this brand is not intended as a substitute for medical advice, and you should not take any action before consulting with a healthcare professional. Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of the most notable news stories of the time. As of Aug. 9, 2021, Pfizer had 5,606,688,356 shares of voting common stock outstanding.
In 2020, Pfizer co-developed with BioNTech SE a vaccine against COVID-19, the virus whose rapid spread prompted the World Health Organization (WHO) to declare a global pandemic in March 2020. On Dec. 11, 2020, the Pfizer-BioNTech vaccine became the first COVID-19 vaccine to receive emergency use asian bond market review & outlook authorization (EUA) from the U.S. The vaccine was approved for emergency use for individuals 16 years of age and older.
The Food and Drug Administration on Thursday gave Pfizer Inc. and Moderna Inc. approval for updated COVID-19 vaccines, as a summer wave of the virus is still rolling across the country. You can get vaccinated against COVID at no cost if you have Medicare, Medicaid, or private insurance, according to Dr. Cohen. But if you’re uninsured or underinsured, free shots may be harder to come by due to the closing of the CDC’s Bridge Access Program in August.
- The FDA gave the vaccine full approval on Aug. 23, 2021, after reviewing the biologics license application (BLA) submitted by Pfizer and BioNTech.
- It sure can—and the same is true of past COVID shots.
- Regardless of your reaction, though, the vaccine is still doing its job.
Pfizer indicated that its COVID-19 shot and Paxlovid treatment for the virus will generate $8 billion in sales next year, versus the approximately $12.5 billion it expects to make on those products this year. The drug maker indicated it expects 2024 revenue to be in a range of $58.5 billion to $61.5 billion, up slightly from this year’s outlook of $58 billion to $61 billion. Albert Bourla, who has been with Pfizer for more than 25 years, is currently the company’s chief executive officer (CEO) and chairman. Before assuming the CEO position in January 2019, he was chief operating officer (COO) starting in January 2018. From February 2016 to December 2018, Bourla was group president of Pfizer’s Global Vaccines, Oncology, and Consumer Healthcare business.
The FDA gave the vaccine full approval on Aug. 23, 2021, after reviewing the biologics license application (BLA) submitted by Pfizer and BioNTech. The two companies completed their submission of the BLA in May 2021. It was the first COVID-19 vaccine to receive full approval from the FDA. It is now being marketed under the name Comirnaty. Shares of Pfizer (PFE) and American depositary receipts (ADRs) of BioNTech (BNTX) dropped in intraday trading Friday following disappointing results from a late-stage study of the drugmakers' combined...
Dividend Charts
Of course, you may be thinking, Do I really need another shot if I is apple stock poised to rise after declining 10% over the last month have four years’ worth of immunity? First, protection from both infections and vaccination generally wanes over time (it only lasts about three months) so you could still get super sick if you catch COVID. Dr. Cohen did say, however, that the CDC has allotted $62 million to state and local immunization programs so they can buy updated COVID shots for people without insurance or those whose policies don’t cover all vaccine-related costs. If you fall into this category, Dr. Cohen recommends reaching out to your local health department to see if they’re offering free vaccines.
Recent Developments
The pharmaceutical firm noted it projects $3.1 billion in 2024 sales from its $43 billion acquisition of cancer drug maker Seagen in February. That deal was approved by U.S. regulators this week, and Pfizer expects it to close tomorrow. In the meantime, remember that your personal risk for getting seriously sick with COVID isn’t necessarily the same as those around you, including your coworkers, Pilates classmates, or fellow grocery shoppers. It sure can—and the same is true of past COVID shots. Basically, vaccines reduce the chances you come down with a serious case of the disease and that you get infected at all.
Pfizer is classified as a member of the S&P 500 healthcare sector and operates within the biotechnology and pharmaceutical industry. Inc. (MRK), Switzerland-based Roche Holding AG (RHHBY), and Eli Lilly and Co. (LLY). Pfizer reported adjusted net income attributable to its common shareholders of $25.2 billion on $81.3 billion in annual revenue in its 2021 fiscal year (FY). You can get any of the three updated shots as soon as you’re able to book an appointment, but if you were vaccinated against COVID recently, you’ll want to wait at least two months after your last dose, the FDA says. That way you can maximize the amount of protection you have against the virus.
Readers Identify 25 Ideal July Dividend Buys Out Of 37 Picks
The company traces its origins to the founding of Charles Pfizer & Co. in Brooklyn, N.Y., in 1849 by Charles Pfizer and Charles Erhart. The company expanded during the late 1800s and early 1900s, remaining a privately held company until June 1942, when it offered shares of its common stock to the public for the first time. It was the first mass producer of the “miracle drug” penicillin in the 1940s and was generating more than a billion dollars in sales by the early 1970s. Pfizer has become one of the biggest pharmaceutical companies in the world, with a market capitalization of $251.3 billion as of Nov. 3, 2021. Albert Bourla is the pharmaceutical giant’s current chief executive officer (CEO).
Pfizer, BioNTech Combination Flu and COVID-19 Shot Misses 1 of 2 Endpoints
He was president and general manager of the company’s Established Products business from 2010 to 2013. Bourla served in a number of other roles from 1993, when he joined the company, to 2010. On Oct. 29, 2021, the gold and bond yields link explained 2020 FDA extended the EUA for the vaccine to include children ages 5–11. With Pfizer's sales rising in Q2, despite falling sales of Covid-19 products, we think that it may well be the turning point for Pfizer stock.
Pharmaceutical (PPH) stocks have done relatively well this year. The closely watched iShares US Pharmaceutical ETF (IHE) stock has jumped by 16.5%, slightly beating the S&P 500 index, which has risen ...
On May 10, 2021, the FDA expanded the EUA for the Pfizer-BioNTech vaccine to include adolescents ages 12–15. The Food and Drug Administration approved updated Covid vaccines from Pfizer and Moderna, putting the shots on track to reach most Americans in the coming days as the virus surges. The only potential downside of getting all of these shots at once is that you might deal with more or stronger (but totally normal) side effects, like headache, fatigue, muscle aches, chills, fever, and nausea. They will go away in a few days, and you can certainly take steps to feel better after you get vaccinated, like taking over-the-counter pain relievers if your doctor says it’s safe and applying a cool washcloth to your arm. BOTHELL, Wash.—At a recent company town hall here, Pfizer's cancer-business chief looked over some 100 scientists, marketers and other staffers who had just joined the giant drugmaker through a $43 bi...
